Assembly Biosciences - Stock Split History | ASMB

Stock split history for Assembly Biosciences since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Assembly Biosciences Annual Stock Splits
Assembly Biosciences Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.433B $0.015B
Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $60.820B 11.09
Teva Pharmaceutical Industries (TEVA) Israel $10.724B 4.36
Bausch Health Cos (BHC) Canada $10.295B 6.79
Mylan (MYL) United States $9.817B 4.40
Dr Reddy's Laboratories (RDY) India $6.712B 17.61
ASPEN PHARMACR (APNHY) South Africa $3.433B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.190B 11.52
Amphastar Pharmaceuticals (AMPH) United States $0.899B 46.71
Homology Medicines (FIXX) United States $0.774B 0.00
Voyager Therapeutics (VYGR) United States $0.512B 0.00
Akorn (AKRX) United States $0.471B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.431B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.276B 0.38
Adamas Pharmaceuticals (ADMS) United States $0.184B 0.00
Sol-Gel Technologies (SLGL) Israel $0.161B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.132B 0.00
CymaBay Therapeutics (CBAY) United States $0.120B 0.00
Teligent (TLGT) United States $0.033B 0.00
China Pharma Holdings (CPHI) China $0.010B 0.00